Alex Berenson
@AlexBerenson
·
51m
JUST A REMINDER THAT NO HEALTH AUTHORITY - NOT IN ENGLAND, NOT IN SCOTLAND, NOT ISRAEL - HAS SEEN FIT TO PUBLISH NUMBERS OF ALL-CAUSE HOSPITALIZATIONS OR DEATHS IN A POST-VACCINATED POPULATION.
Gee, I wonder why.
8
227
704
Alex Berenson
@AlexBerenson
·
59m
4/ Again, some protection is better than none, and the over-80s reported fewer side effects. So the cost-benefit still suggests they should take it. But this is another nail in the umm coffin of the theory the vaccines are magically going to end the epidemic.
20
24
133
Show this thread
Alex Berenson
@AlexBerenson
·
1h
3/ And why a fair number of vaccinated people are still getting sick and dying. As with the flu vaccine, Come-here-naughty works great except for the people who really need it. Link:
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
medrxiv.org
2
28
112
Show this thread
Alex Berenson
@AlexBerenson
·
1h
2/ Compared to only 2% of the younger group. And 17 days after 1 dose, only 1% of the older group (and 16% of the younger) had neutralizing antibodies.
This is the cell-level answer to the question of why Israel reported few gains into February. One dose is nearly useless...
8
32
130
Show this thread
Alex Berenson
@AlexBerenson
·
1h
1/ Wow. This is the paper I’ve been waiting for. German researchers examined how well the
@pfizer
vaccine worked in people over 80 compared to under 60.
The answer: not well at all. 17 days after the second dose - peak protection - 1/3 had NO neutralizing antibodies...
So how does ivermectin stack up against Pfizer for the elderly?